Drug repurposing in COVID-19: A review with past, present and future
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference46 articles.
1. Coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
2. Isolation of a Novel coronavirus from a Man with Pneumonia in Saudi Arabia;Zaki,2012
3. Coronavirus genomics and bioinformatics analysis;Woo;Viruses,2010
4. Structure of the RNA-dependent RNA polymerase from COVID-19 virus;Gao;Science,2020
5. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;mBio,2018
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management;Current Topics in Medicinal Chemistry;2024-08
2. Antiviral potential of withaferin A and titanium dioxide nanoparticle (TiO2-np) complex against spike protein (Spro) of omicron variant: An in silico approach;Annals of Phytomedicine An International Journal;2024-07
3. Repurposing as a response to combat the COVID-19 pandemic – a case of an automobile component manufacturer;Operations Management Research;2024-05-28
4. Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review;Clinical Pharmacology: Advances and Applications;2024-01
5. Drug repurposing for respiratory infections;Progress in Molecular Biology and Translational Science;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3